As per the SEBI Circular No. CIR/CFD/CMD1 /162/2019 dated December 24, 2019, issued by the SEBI titled ‘Format on Statement of Deviation or Variation for proceeds of public issue, rights issue, preferential issue, Qualified Institutions Placement (QIP) etc’ and pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, JHS Svendgaard Laboratories has informed that it has enclosed a Nil statement issued by the Company on the captioned subject.
The above information is a part of company’s filings submitted to BSE.
